Total Payments
$3,983
2024 Payments
$799.57
Companies
35
Transactions
155
Medicare Patients
2,594
Medicare Billing
$462,205
Payment Breakdown by Category
Food & Beverage$3,908 (98.1%)
Education$74.60 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,908 | 148 | 98.1% |
| Education | $74.60 | 7 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $733.29 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $407.09 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $367.10 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $279.12 | 13 | $0 (2024) |
| PFIZER INC. | $256.62 | 8 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $229.04 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $208.06 | 5 | $0 (2024) |
| Genentech USA, Inc. | $177.21 | 5 | $0 (2018) |
| Celgene Corporation | $158.29 | 8 | $0 (2024) |
| Allergan Inc. | $107.40 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $799.57 | 36 | Daiichi Sankyo Inc. ($158.47) |
| 2023 | $771.89 | 22 | GENZYME CORPORATION ($216.28) |
| 2022 | $404.49 | 20 | GENZYME CORPORATION ($244.87) |
| 2021 | $469.30 | 16 | GENZYME CORPORATION ($123.98) |
| 2020 | $325.74 | 14 | Daiichi Sankyo Inc. ($187.54) |
| 2019 | $201.59 | 6 | Allergan Inc. ($107.40) |
| 2018 | $417.88 | 10 | AstraZeneca Pharmaceuticals LP ($222.97) |
| 2017 | $592.19 | 31 | PFIZER INC. ($142.92) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $19.04 | General |
| Category: Oncology | ||||||
| 11/04/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.53 | General |
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.09 | General |
| 10/28/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $43.19 | General |
| Category: Oncology | ||||||
| 10/21/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Oncology | ||||||
| 07/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.60 | General |
| Category: Hematology/Oncology | ||||||
| 07/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $21.00 | General |
| 06/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Oncology | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.29 | General |
| 06/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 515 | 1,120 | $248,177 | $97,481 |
| 2022 | 8 | 520 | 1,097 | $238,366 | $105,216 |
| 2021 | 9 | 561 | 1,330 | $272,918 | $146,614 |
| 2020 | 11 | 998 | 2,079 | $221,335 | $112,894 |
Total Patients
2,594
Total Services
5,626
Medicare Billing
$462,205
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 460 | $121,624 | $51,122 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 251 | 453 | $87,330 | $32,064 | 36.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 45 | 45 | $18,360 | $6,180 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 73 | $9,924 | $3,285 | 33.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 34 | $4,216 | $2,131 | 50.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,191 | $1,510 | 36.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 30 | $2,220 | $1,178 | 53.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 14 | $312.00 | $11.62 | 3.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 116 | 444 | $117,216 | $50,986 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 233 | 386 | $73,340 | $28,841 | 39.3% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 22 | 77 | $12,320 | $12,283 | 99.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 53 | 53 | $21,624 | $7,476 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 54 | $7,160 | $2,785 | 38.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 34 | $4,216 | $1,936 | 45.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 29 | $2,030 | $896.63 | 44.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 11 | 20 | $460.00 | $11.57 | 2.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 139 | 515 | $129,483 | $59,084 | 45.6% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 48 | 299 | $47,840 | $48,555 | 101.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 212 | 307 | $56,426 | $23,231 | 41.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 54 | 54 | $21,559 | $8,036 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 46 | $5,704 | $2,686 | 47.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $4,911 | $2,306 | 47.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 30 | $3,855 | $1,590 | 41.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 35 | $2,450 | $1,125 | 45.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 12 | 30 | $690.00 | $2.30 | 0.3% |
About Dr. Aisha Zaidi, MD
Dr. Aisha Zaidi, MD is a Hematology & Oncology healthcare provider based in Mechanicsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770770281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aisha Zaidi, MD has received a total of $3,983 in payments from pharmaceutical and medical device companies, with $799.57 received in 2024. These payments were reported across 155 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,908).
As a Medicare-enrolled provider, Zaidi has provided services to 2,594 Medicare beneficiaries, totaling 5,626 services with total Medicare billing of $462,205. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Mechanicsville, VA
- Active Since 09/28/2007
- Last Updated 03/17/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1770770281
Products in Payments
- SARCLISA (Biological) $453.68
- Enhertu (Drug) $312.49
- ELITEK (Biological) $279.61
- KEYTRUDA (Biological) $208.06
- IBRANCE (Drug) $178.52
- KISQALI (Drug) $142.55
- TAGRISSO (Drug) $124.99
- myRisk (Device) $119.20
- PRECISETUMOR (Device) $109.84
- NATRELLE (Device) $107.40
- LYNPARZA (Drug) $97.98
- Lenvima (Drug) $93.37
- Revlimid (Drug) $90.58
- IMBRUVICA (Drug) $90.45
- IMFINZI (Biological) $86.94
- JAKAFI (Drug) $71.66
- INJECTAFER (Drug) $54.61
- QINLOCK (Drug) $54.13
- ADCETRIS (Biological) $49.77
- BRAFTOVI (Drug) $46.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mechanicsville
Maura Hagan, M.d, M.D
Hematology & Oncology — Payments: $7,119
Hematology & Oncology $7,119
Seaborn Wade, M.d, M.D
Hematology & Oncology — Payments: $3,820
Hematology & Oncology $3,820
Angela Vanlandingham, M.d, M.D
Hematology & Oncology — Payments: $3,618
Hematology & Oncology $3,618
Maurice Schwarz, M.d, M.D
Hematology & Oncology — Payments: $2,510
Hematology & Oncology $2,510